June 2020 | In response to the global outbreak of COVID-19, CrossLife Technologies has developed the IsoTARATM COVID-19 Colorimetric Assay to perform near point-of-care where sample extraction is not necessary. The IsoTARA amplification processes...
Read moreCrossLife Tech’s Molecular Test for the Novel Coronavirus, CLT™ SARS-CoV-2 qRT-PCR, Has Developed.
June 2020 | In response to the global outbreak of the novel coronavirus disease (COVID-19), CrossLife Technologies has developed a real-time RT-PCR test, CLT™ SARS-CoV-2 qRT-PCR Assay, intended for the qualitative detection of nucleic acid...
Read moreCrossLife Awarded NIH SBIR II Grant for HIV Point-of-Care Diagnostic
August 2018 | CrossLife has recently been awarded a Phase II Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test for the Point of Care Detection of HIV virus. Point-of-Care Rapid RNA test for...
Read moreServe on Special Emphasis Review Panel
March 2017 | CrossLife founder & Chief Executive Officer, Dr. HyunDae Cho has been asked to serve on Special Emphasis Review Panel by the National Institutes of Health (U.S. NIH), Bioanalytical Chemistry, Biophysics, and Assay Development...
Read moreCrossLife on the News for NCATS Feature Story
CrossLife was on an NCATS feature story about SBIR grantees and NIH I-Corps training. https://ncats.nih.gov/pubs/features/sbir-i-corps NIH I-Corps Training Helps NCATS-Supported Companies Find Their Way Learning what customers want I-Corps...
Read moreCrossLife Awarded NIH SBIR Grant for Zika Point-of-Care Diagnostic
January 2017 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test for the Point of Care Detection of Zika virus.
Read moreServe on Two Special Emphasis Review Panels
October 2016 | CrossLife founder & Chief Executive Officer, Dr. HyunDae Cho has been asked to serve on two Special Emphasis Review Panel by the National Institutes of Health (U.S. NIH), Bioanalytical Chemistry, Biophysics, and Assay...
Read moreCrossLife Awarded NIH SBIR Grant for Chikungunya Point-of-Care Diagnostic
July 2016 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test for the Detection of Chikungunya at the Point of Care  ...
Read moreCrossLife Awarded NIH SBIR Grant for HIV Point-of-Care Diagnostic
July 2016 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for Point-of-Care Rapid RNA test for HIV  ...
Read moreCrossLife successfully finished the NIH I-Corps entrepreneur immersion program
June 2016 | We have successfully finished the NIH I-Corps entrepreneur immersion program (March 2016- May 2016). We have assembled an I-Corp team composed of an experienced industry expert who is a Key Opinion Leader in the diagnostics industry...
Read moreCrossLife Awarded NIH SBIR Grant for Influenza Virus Point-of-Care Diagnostic
May 2016 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NCATS for Point-of-Care Rapid RNA Diagnosis of Influenza Virus  ...
Read moreCrossLife selected for the NIH I-Corps entrepreneur immersion training program
March 2016 | NIH I-Corps | CrossLife has been selected for the highly competitive NIH I-Corps entrepreneur immersion training program. The goal of the program is to identify customers and markets for our point-of-care dengue diagnostic, and to...
Read more